Cargando…
PET imaging of PARP expression using (68)Ga-labelled inhibitors
PURPOSE: Imaging the PARP expression using (18)F probes has been approved in clinical trials. Nevertheless, hepatobiliary clearance of both (18)F probes hindered their application in monitoring abdominal lesions. Our novel (68)Ga-labelled probes aim for fewer abdominal signals while ensuring PARP ta...
Autores principales: | Wang, Xiangwei, Liu, Wei, Li, Ke, Chen, Kaiwen, He, Simin, Zhang, Jianping, Gu, Bingxin, Xu, Xiaoping, Song, Shaoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317875/ https://www.ncbi.nlm.nih.gov/pubmed/37145164 http://dx.doi.org/10.1007/s00259-023-06249-6 |
Ejemplares similares
-
(68)Ga-FAPI and (18)F-FDG PET/CT Images in a Patient With Extrapulmonary Tuberculosis Mimicking Malignant Tumor
por: Gu, Bingxin, et al.
Publicado: (2020) -
Head-to-head evaluation of [(18)F]FDG and [(68) Ga]Ga-DOTA-FAPI-04 PET/CT in recurrent soft tissue sarcoma
por: Gu, Bingxin, et al.
Publicado: (2022) -
The Added Value of (68)Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with (18)F-FDG–Negative Findings
por: Gu, Bingxin, et al.
Publicado: (2022) -
Gallium-68 Labeling of the Cyclin-Dependent Kinase
4/6 Inhibitors as Positron Emission Tomography Radiotracers for Tumor
Imaging
por: Liu, Cheng, et al.
Publicado: (2021) -
Multifarious Ga-68 Labeled PET Radiopharmaceuticals in Imaging Various Malignancies
por: Vatsa, Rakhee, et al.
Publicado: (2018)